Century Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €5.68M +194.8% -€109.04M -7.4% -1,920.9% +42 pp -€94.75M +47.4% -1,669.2% +17 pp
    €1.93M -57.0% -€117.75M +4.4% -6,115.1% -36 pp -€64.28M -267.1% -3,338.3% -42 pp
    €4.48M +∞% -€112.80M +36.6% -2,518.4% -25 pp €38.47M -201.4% 858.9% +8.6 pp
    €0.00 +NaN% -€82.56M +75.3% N/A -€37.94M +40.0% N/A
    €0.00 +NaN% -€47.09M -77.8% N/A -€27.09M +129.4% N/A
    €0.00 -€211.92M N/A -€11.81M N/A

    Notifications